Moreover, we also found that the high TOP2A expression predicted poor overall survival compared with the low TOP2A expression in HCC patients with tumor stage 2 (log-rank P = 0.0073, Figure 7(i)) and tumor stage 3 (log-rank P = 0.00066, Figure 7(j)). Here, TOP2A is linked to hepatocellular carcinoma.